MUNICH, Germany—Although use of an intra-aortic balloon pump (IABP) in patients with acute myocardial infarction (AMI) complicated by cardiogenic shock appears safe, the technique does not improve ...
Please provide your email address to receive an email when new articles are posted on . Datascope/Getinge announced a recall of its intra-aortic balloon pumps due to risk for blood entering the pump ...
The FDA announced that Maquet Datascope Corp. has recalled a hybrid intra-aortic balloon pump due to a design issue that allows fluid, such as saline, to seep into the device. The agency designated ...
PARIS — Early implantation of an intra-aortic balloon pump (IABP) in patients with decompensated heart failure (HF) and low output provided more effective treatment than inotropic agents in a small ...
The Benchmark Counterpulsation Outcomes Registry is perhaps the most robust barometer of real-world contemporary IABP practice we have at our disposal. The first report, published in 2001, documented, ...
The NyokAssist device, from China, had few adverse outcomes by 30 days. More devices—and more trials—are on the way.
Getinge is recalling 4,338 intra-aortic balloon pumps after discovering fluid leaks that can lead to unexpected shutdowns or the inability to initiate therapy, the FDA said Dec. 16. The agency has ...
MUNICH and WAYNE, N.J., Aug. 27, 2012 /PRNewswire/ -- MAQUET Cardiovascular LLC, the market leader in intra-aortic balloon counterpulsation therapy, today announced 30-day results from the large, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback